Literature DB >> 17291284

Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?

Aurélie Thedrez1, Caroline Sabourin, Julie Gertner, Marie-Claire Devilder, Sophie Allain-Maillet, Jean-Jacques Fournié, Emmanuel Scotet, Marc Bonneville.   

Abstract

Although gammadelta T cells express clonally distributed T-cell receptors (TCRs), a hallmark of adaptive immunity, they are classically considered as innate-like effectors, owing to the high frequency of preactivated gammadelta T cells, with restricted antigen recognition repertoire in particular tissue locations. Actually, such features are shared only by a fraction of gammadelta T-cell subsets located in the skin and reproductive organ mucosa in rodents or in peripheral blood in humans. By contrast, other gammadelta subsets, e.g. those found in rodent and human spleen, show diverse antigenic reactivity patterns and mixed naive/memory phenotypes. Thus, gammadelta T cells are made of both 'primitive' subsets endowed with innate-like properties and 'evolved' subsets able to mount anamnestic responses like conventional major histocompatibility complex-restricted alphabeta T cells. In this article, we show that human gammadelta T cells, although heterogeneous, do share recurrent innate features that distinguish them from mainstream alphabeta T cells. In particular, most of them are activated on TCR- or natural killer receptor-mediated recognition of a restricted set of conserved yet poorly defined endogenous stress determinants. This rather simple recognition mechanism allows human gammadelta T cells to discriminate healthy cells from altered cells and to exert a variety of immunostimulatory or regulatory functions. The recent availability of synthetic gammadelta T-cell agonists mimicking these natural stress-induced ligands have fostered development of immunotherapeutic strategies, with broad indications against infectious and tumor diseases, which are briefly reviewed here.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17291284     DOI: 10.1111/j.1600-065X.2006.00468.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  60 in total

1.  ATP release and autocrine signaling through P2X4 receptors regulate γδ T cell activation.

Authors:  Monali Manohar; Mark I Hirsh; Yu Chen; Tobias Woehrle; Anjali A Karande; Wolfgang G Junger
Journal:  J Leukoc Biol       Date:  2012-06-29       Impact factor: 4.962

Review 2.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

Review 3.  Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity.

Authors:  Marc Bonneville; Rebecca L O'Brien; Willi K Born
Journal:  Nat Rev Immunol       Date:  2010-06-11       Impact factor: 53.106

4.  IL-17 regulates adipogenesis, glucose homeostasis, and obesity.

Authors:  Luis A Zúñiga; Wen-Jun Shen; Barbara Joyce-Shaikh; Ekaterina A Pyatnova; Andrew G Richards; Colin Thom; Sofia M Andrade; Daniel J Cua; Fredric B Kraemer; Eugene C Butcher
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

5.  Definition of APC presentation of phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate to Vgamma2Vdelta 2 TCR.

Authors:  Huiyong Wei; Dan Huang; Xiaomin Lai; Meiling Chen; Weihua Zhong; Richard Wang; Zheng W Chen
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 6.  Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside.

Authors:  Barbara Castella; Candida Vitale; Marta Coscia; Massimo Massaia
Journal:  Cell Mol Life Sci       Date:  2011-05-17       Impact factor: 9.261

Review 7.  Human gamma delta T cells: Evolution and ligand recognition.

Authors:  Erin J Adams; Siyi Gu; Adrienne M Luoma
Journal:  Cell Immunol       Date:  2015-05-06       Impact factor: 4.868

8.  Highly active microbial phosphoantigen induces rapid yet sustained MEK/Erk- and PI-3K/Akt-mediated signal transduction in anti-tumor human gammadelta T-cells.

Authors:  Daniel V Correia; Francisco d'Orey; Bruno A Cardoso; Telma Lança; Ana R Grosso; Ana deBarros; Leila R Martins; João T Barata; Bruno Silva-Santos
Journal:  PLoS One       Date:  2009-05-21       Impact factor: 3.240

9.  A functional gammadeltaTCR/CD3 complex distinct from gammadeltaT cells is expressed by human eosinophils.

Authors:  Fanny Legrand; Virginie Driss; Gaëtane Woerly; Sylvie Loiseau; Emmanuel Hermann; Jean-Jacques Fournié; Laurent Héliot; Virginie Mattot; Fabrice Soncin; Marie-Lise Gougeon; David Dombrowicz; Monique Capron
Journal:  PLoS One       Date:  2009-06-17       Impact factor: 3.240

10.  T10B9 monoclonal antibody: a short-acting nonstimulating monoclonal antibody that spares gammadelta T-cells and treats and prevents cellular rejection.

Authors:  Thomas H Waid; John S Thompson; Maria Siemionow; Stephen A Brown
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.